Real-world study of GLP-1 patients continues to deliver leading insights

Real-world, integrated data follows-up on previous insights, analytics.

Prime to present seven studies and receive the 2024 JMCP Award for Excellence

As demand for GLP-1a drugs for weight loss has increased, new data provides additional insights about this new class of medications.

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.

Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.

Identifying and managing diabetes and weight loss therapies earns AMCP platinum award

13th annual report the preeminent source for medical benefit drug trend